What Were Reading: Symlin and Pregnancy

This week, we’d like to direct your attention to this post at entitled “Symlin—yes or no!?” The post, written by Kelly Close (a writer, editor, and consultant who has Type 1 diabetes), examines her dilemma about whether to use the injectable drug pramlintide (brand name Symlin) to help lower her HbA1c level during pregnancy.

For more information about Symlin, please visit Jan Chait’s blog entry “Symlin: Sometimes the Positives Outweigh the Negatives.” Read More “What Were Reading: Symlin and Pregnancy”

Inhaled Insulin Passes Test for Safety

Inhaled insulin (brand name Exubera) has been getting some negative press lately, focusing on its high price, large inhaler, slow sales, and concerns about its effects on lung function. While the results of a new study may not be able to do much to address the first three issues, they have shown inhaled insulin to be safe for the lungs and effective for diabetes management over a two-year period of use. Read More “Inhaled Insulin Passes Test for Safety”

What We’re Reading: “His First Syringe”

This week, we’d like to direct your attention to this post at In it, blogger Kerri relates the story of teaching her partner, Chris, how to give her an insulin injection. This blog is written by Kerri Morrone, a writer and editor with Type 1 diabetes.

And as a reminder, today is the final day during which you can nominate The Diabetes Self-Managment Blog for “Best Blog” and “Best Professional News Blog” over at The Diabetes O.C.. You can go straight to the nominating page, or read more about the awards in this previous “What We’re Reading” post. Read More “What We’re Reading: “His First Syringe””

Mixed Results in Islet Transplantation Study

For years, the transplantation of insulin-producing pancreatic islet cells has held promise as a potential cure for Type 1 diabetes. Now, a new study has shown that while transplantation can help recipients improve their blood glucose control, the transplanted cells tend to lose function progressively, requiring most recipients to resume insulin injections within two years. Read More “Mixed Results in Islet Transplantation Study”

Get Diabetes-Friendly Recipes In Your Inbox

Sign up for Free

Stay Up To Date On News & Advice For Diabetes

Sign up for Free

Get On Track With Daily Lifestyle Tips

Sign up for Free

Save Your Favorites